University of Washington

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Sangamo Partners In Neurology With Lill

Gilead Sciences, Inc. secured the dominant position in HIV therapy years ago, but maintaining that lead has taken an aggressive research and development effort aimed at optimizing current therapy for

Athenex Taps NCI TCRs For Solid Tumor Off-The-Shelf Therapy Athenex, Inc. announced a licensing agreement on 9 November with the US National Cancer Institute (NCI) to expand its development capabil

Icosavax, Inc. advanced its virus-like particle (VLP) technology platform for the creation of novel vaccines that prevent respiratory diseases and scaled up manufacturing to support clinical trials w